Aligned Genetics Inc Cash Flow Quality Index
Aligned Genetics Inc cash flow quality index. Aligned Genetics Inc (238120) has a Cash Flow Quality Index of -2.19x as of September 2025. Operating cash flow of ₩-2.04 Billion is below net income of ₩933.05 Million, suggesting accrual-heavy earnings not yet converted to cash. See Aligned Genetics Inc (238120) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Aligned Genetics Inc (2019–2024)
Cash flow quality index of Aligned Genetics Inc from 2019 to 2024. Historical Cash Flow Quality Index for Aligned Genetics Inc across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Aligned Genetics Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Aligned Genetics Inc Cash Flow Quality Index by Year (2019–2024)
Aligned Genetics Inc cash flow quality index by year from 2019 to 2024. Year-by-year earnings quality comparison for Aligned Genetics Inc. For the full cash flow conversion analysis, see how efficiently does Aligned Genetics Inc generate cash.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.74x | ₩3.07 Billion | ₩4.13 Billion | ▼ -15.6% |
| 2023 | 0.88x | ₩2.85 Billion | ₩3.24 Billion | ▼ -7.6% |
| 2022 | 0.95x | ₩2.22 Billion | ₩2.33 Billion | ▲ +3782.9% |
| 2021 | 0.02x | ₩135.97 Million | ₩5.54 Billion | ▼ -67.8% |
| 2020 | 0.08x | ₩35.67 Million | ₩468.23 Million | ▼ -98.7% |
| 2019 | 5.65x | ₩659.29 Million | ₩116.74 Million | — |